Q4 Earnings Estimate for Balchem Issued By HC Wainwright

Balchem Co. (NASDAQ:BCPC) – Investment analysts at HC Wainwright issued their Q4 2026 earnings per share (EPS) estimates for Balchem in a research report issued to clients and investors on Monday, February 24th. HC Wainwright analyst R. Selvaraju anticipates that the basic materials company will earn $1.22 per share for the quarter. HC Wainwright has a “Buy” rating and a $190.00 price objective on the stock. The consensus estimate for Balchem’s current full-year earnings is $4.64 per share.

Balchem (NASDAQ:BCPC) last released its quarterly earnings results on Friday, February 21st. The basic materials company reported $1.03 earnings per share for the quarter, missing the consensus estimate of $1.11 by ($0.08). The company had revenue of $240.00 million for the quarter, compared to analyst estimates of $239.96 million. Balchem had a return on equity of 11.37% and a net margin of 13.47%.

Separately, StockNews.com raised shares of Balchem from a “hold” rating to a “buy” rating in a research note on Monday, October 28th.

Balchem Stock Up 1.1 %

Shares of BCPC opened at $165.57 on Tuesday. The stock has a 50 day moving average price of $161.98 and a 200 day moving average price of $169.37. Balchem has a one year low of $137.69 and a one year high of $186.03. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.16 and a current ratio of 1.99. The stock has a market capitalization of $5.38 billion, a price-to-earnings ratio of 42.13, a PEG ratio of 4.41 and a beta of 0.69.

Balchem Increases Dividend

The company also recently declared an annual dividend, which was paid on Friday, January 17th. Stockholders of record on Thursday, December 26th were given a dividend of $0.87 per share. This is a positive change from Balchem’s previous annual dividend of $0.79. This represents a dividend yield of 0.4%. The ex-dividend date of this dividend was Thursday, December 26th. Balchem’s dividend payout ratio (DPR) is currently 22.14%.

Institutional Investors Weigh In On Balchem

Large investors have recently added to or reduced their stakes in the business. Covestor Ltd increased its holdings in Balchem by 93.8% during the 4th quarter. Covestor Ltd now owns 157 shares of the basic materials company’s stock worth $26,000 after purchasing an additional 76 shares during the period. Westside Investment Management Inc. purchased a new stake in shares of Balchem in the 3rd quarter valued at approximately $27,000. R Squared Ltd purchased a new position in Balchem in the fourth quarter valued at $29,000. Federated Hermes Inc. acquired a new stake in shares of Balchem during the 4th quarter worth about $33,000. Finally, Wilmington Savings Fund Society FSB purchased a new stake in Balchem during the third quarter worth approximately $35,000. 87.91% of the stock is owned by hedge funds and other institutional investors.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.